跳至主要内容
临床试验/NL-OMON56615
NL-OMON56615尚未招募不适用

Performance of a new real-time continuous glucose monitoring system: a validation study of the idi-CGM in type 1 diabetes - Validation MySensible idi-CGM

Isala Klinieken0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - presence of type 1 DM;
  • - age between 18 and 75 years old.

排除标准

  • - A history of allergies towards (microneedle) patch substances/adhesive;
  • - The inability to understand the Dutch language;
  • - Oral of injected steroid using within the past 3 months
  • - Pregnancy or planned pregnancy
  • - Uncontrolled thyroid disease or hypertension
  • - Poor visual acuity
  • - Inability or unwillingness to meet the protocol requirements
  • - Any severe or uncontrolled medical or psychological condition which, in the
  • opinion of the investigator, would compromise the ability to meet protocol
  • requirements.

研究者

发起方
Isala Klinieken

相似试验